Press Room

Share

Legislation Filed Aimed at Expanding Access to Game-changing Biomarker Testing

The American Cancer Society Cancer Action Network (ACS CAN) Supports Legislation Filed by Rep. White That Expands Access to Precision Medicine Testing and would Improving Health Outcomes for Ohioans

January 24, 2025

COLUMBUS, OHIO —Rep. Andrea White has reintroduced legislation that would increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. Despite its benefits, access to biomarker testing has not kept pace with the rate of innovation due to several barriers, including lack of coverage by private health insurance and Medicaid programs, which Rep. White’s legislation would fix.

“Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role in improving cancer outcomes,” said Leo Almeida, government relations director, ACS CAN. “Over 77,000 Ohioans will be diagnosed with cancer this year. Ensuring patients who could benefit have access to insurance-covered biomarker testing gives them the best chance of survival.” 

ACS CAN thanks Rep. White for continuing to champion this important next step in ensuring cancer patients have access to precision medicine. Twenty other states have enacted biomarker legislation, and ACS CAN looks forward to working with the rest of the legislature to enact this critical legislation. 

More Press Releases AboutAccess to Biomarker Testing, Ohio

Media Contacts

Michelle Zimmerman
Associate Director, Regional Media Advocacy
[email protected]
Cell:740.525.9577

Related Press Releases

January 17, 2025

New Study Shows Cancer Rates Rising in Women; Advocates Urge Hawaii State Lawmakers to Support Cancer Fight in 2025

HONOLULU – A new report from the American Cancer Society (ACS) released Thursday shows cancer diagnoses are now higher in women compared to men, revealing a shift in the burden of the disease. The report highlights and presents an opportunity for Hawaii State Lawmakers to work with the American Cancer Society Cancer Action Network (ACS CAN) to support cancer prevention, treatment, and access to care during the 2025 legislative session.  

Read More
January 15, 2025

Governor Murphy Sets Sights on Affordability Concerns in 2025, Advocates Applaud & Urge Lawmakers to Prioritize Patients across Cancer Continuum

The following is a statement from American Cancer Society Cancer Action Network (ACS CAN) New Jersey Government Relations Director Quinton Law:

“As anybody touched by the disease can tell you, cancer demands a high price. Physically, emotionally and financially, it is a draining disease where the costs can—very quickly—feel insurmountable. This is the case for patients across the cancer continuum. New Jerseyans are looking for state leaders to intervene and prevent the costs of care from trending upward and potentially trapping them in a lifetime of medical debt. Cancer patients and survivors throughout the state were heartened to hear Governor Murphy isolate affordability as a priority in his State of the State address. In the coming year, ACS CAN urges lawmakers to focus their efforts on three areas to alleviate the financial burden of disease, starting with preventing illness for a group of New Jerseyans at heightened risk of cancer: Atlantic City casino workers.

Read more
January 13, 2025

Advocates Call on Washington Lawmakers to Prioritize Expanding Access to Biomarker Testing

OLYMPIA, Wash. -- As Washington legislators convene today for a new session, American Cancer Society Cancer Action Network advocates will ask them to prioritize patients' ready access to needed and proven biomarker testing.

Read more